Abstract: A mirror unit 2 includes a mirror device 20 including a base 21 and a movable mirror 22, an optical function member 13, and a fixed mirror 16 that is disposed on a side opposite to the mirror device 20 with respect to the optical function member 13. The mirror device 20 is provided with a light passage portion 24 that constitutes a first portion of an optical path between the beam splitter unit 3 and the fixed mirror 16. The optical function member 13 is provided with a light transmitting portion 14 that constitutes a second portion of the optical path between the beam splitter unit 3 and the fixed mirror 16. A second surface 21b of the base 21 and a third surface 13a of the optical function member 13 are joined to each other.

Abstract: The amount of carbon dioxide absorbed by plants grown in a field can more accurately be estimated based on environmental information of the field. A plurality of types of mutually-differing environmental information are measured regarding an installation field. For the plurality of types of environmental information, the correspondence relationship between each type of environmental information and a carbon dioxide (CO2) absorption amount is stored. A plurality of CO2 absorption amounts are acquired by referring to the respective correspondence relationship for each type of measured environmental information. The acquired plurality of CO2 absorption amounts are compared with each other and the minimum value thereof is selected as the estimated value. Information regarding the selected estimated value is displayed.

Abstract: The amount of carbon dioxide absorbed by plants grown in a field can more accurately be estimated based on environmental information of the field. A plurality of types of mutually-differing environmental information are measured regarding an installation field. For the plurality of types of environmental information, the correspondence relationship between each type of environmental information and a carbon dioxide (CO2) absorption amount is stored. A plurality of CO2 absorption amounts are acquired by referring to the respective correspondence relationship for each type of measured environmental information. The acquired plurality of CO2 absorption amounts are compared with each other and the minimum value thereof is selected as the estimated value. Information regarding the selected estimated value is displayed.

Abstract: The purpose of the present invention is to improve evaluation accuracy of a photographed image when an event occurs.

Abstract: The purpose of the present invention is to improve evaluation accuracy of a photographed image when an event occurs.

Abstract: With an object of providing an agent for treating hepatic disease by inhibiting occurrence of hepatic disease, in particular portal venous invasion, there is disclosed an agent for treating or preventing hepatic disease containing menatetrenone as an active ingredient thereof. This agent for treating or preventing hepatic disease is effective against hepatic cancer, in particular DCP (des-?-carboxy prothrombin) positive hepatic cancer. Moreover, the agent for treating or preventing hepatic disease containing menatetrenone as an active ingredient thereof according to the present invention exhibits remarkable effects in improving the prognosis after hepatic cancer treatment, and exhibits excellent effects as an agent for inhibiting the recurrence of hepatic cancer.

Abstract: An extracellular matrix protease (MMP) is an enzyme which is expressed in the course of tissue generation and differentiation via repeated cell division of a fertilized egg, and is also closely associated with invasion and metastasis of cancer. Degradation of extracellular matrix around cancer cells and in the vascular basal membrane is a necessary process for invasion and metastasis of cancer. Thus, invasion and metastasis of cancer can be prevented by inhibiting the expression of MMP, but few highly safe drugs that inhibit the expression of MMP have been developed. The present invention provides a drug that inhibits expression of MMP by cancer cells.

Abstract: With an object of providing an agent for treating hepatic disease by inhibiting occurrence of hepatic disease, in particular portal venous invasion, there is disclosed an agent for treating or preventing hepatic disease containing menatetrenone as an active ingredient thereof. This agent for treating or preventing hepatic disease is effective against hepatic cancer, in particular DCP (des-?-carboxy prothrombin) positive hepatic cancer. Moreover, the agent for treating or preventing hepatic disease containing menatetrenone as an active ingredient thereof according to the present invention exhibits remarkable effects in improving the prognosis after hepatic cancer treatment, and exhibits excellent effects as an agent for inhibiting the recurrence of hepatic cancer.